VIP

VIP, short for Vasoactive Intestinal Peptide, is a naturally occurring signaling peptide found throughout the nervous system and the gut. As a therapeutic compound it is used primarily in protocols targeting chronic inflammation, immune dysregulation, and conditions related to biotoxin illness, including CIRS (chronic inflammatory response syndrome). How it works: VIP acts as a regulatory signaling molecule that modulates immune balance, controls inflammatory pathways, and influences blood flow. It helps the body calibrate its inflammatory response rather than suppressing it bluntly. Who tends to use it: VIP protocols are most commonly associated with people dealing with chronic immune dysfunction and inflammatory conditions, particularly those being treated under specialized CIRS protocols. It also has supporting applications for gut function and cognitive symptoms. Its primary goal weight is immune support, with gut health and cognition as secondary targets. What to expect: VIP is not a short-cycle peptide. It is used in longer, closely monitored protocols because its effects on immune regulation require sustained use and regular assessment by the clinician overseeing the protocol. How it is taken: VIP is administered intranasally - as a nasal spray, not an injection. The dose is 50 mcg per spray, taken as several sprays daily. The precise timing and number of sprays per day are set by the protocol. Blood pressure is monitored during VIP use. Safety notes: Blood pressure monitoring is a requirement during VIP protocols. It is a compounded preparation. There are no exclusion flags for pregnancy or cancer history in the current record, but it is used specifically within specialized clinical protocols rather than as a general wellness peptide. Exact protocol structure, spray count, and monitoring plan are established with a licensed provider in the PepDepo network before starting.